THERALASE TECHNOLOGIES INC (TLT.CA) Stock Earnings & Estimates
Canada - TSX Venture Exchange - TSX-V:TLT - CA88337V1004 - Common Stock
0.27 CAD
-0.01 (-1.82%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.139M 45.86% | 1.07M -6.00% | 1.033M -3.45% | 906.4K -12.29% | 2.996M 230.54% | 36.019M 1,102.24% | |
| EBITDA YoY % growth | -4.918M -15.31% | -4.308M 12.40% | -4.016M 6.78% | N/A | N/A | N/A | |
| EBIT YoY % growth | -5.232M -15.19% | -4.594M 12.18% | -4.288M 6.66% | N/A | N/A | N/A | |
| Operating Margin | -459.47% | -429.25% | -414.98% | N/A | N/A | N/A | |
| EPS YoY % growth | N/A 0.32% | N/A | -0.02 44.98% | -0.02 -21.18% | -0.04 -100.00% | 0.01 125.00% |
All data in CAD
| Q4 / 25 | |
|---|---|
| EPS Q2Q % growth | -0.01 -157.50% |
| Revenue Q2Q % growth | 309K -24.63% |
| EBITDA Q2Q % growth | N/A |
| EBIT Q2Q % growth | N/A |
All data in CAD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 0.00 | 0.00 | 0.00 | -29.45% |
| Q2 2025 Q2Q % growth | 0.00 20.00% | 0.00 | 0.00 | 2.91% |
| Q1 2025 Q2Q % growth | -0.01 | 0.00 | 0.00 | -94.17% |
| Q4 2024 Q2Q % growth | 0.00 66.67% | 0.00 | 0.00 | % |
| Q3 2024 Q2Q % growth | 0.00 20.00% | 0.00 | 0.00 | % |
| Q2 2024 Q2Q % growth | -0.01 51.46% | 0.00 | -0.01 | % |
| Q1 2024 Q2Q % growth | -0.01 14.29% | 0.00 | -0.01 | % |
| Q4 2023 Q2Q % growth | -0.01 -50.00% | -0.01 | 0.00 | 41.75% |
| Q3 2023 Q2Q % growth | -0.01 16.67% | -0.01 | 0.01 | 51.46% |
| Q2 2023 Q2Q % growth | -71.67% | -0.01 | % | |
| Q1 2023 Q2Q % growth | -0.01 | -0.01 | 0.00 | 32.04% |
| Q4 2022 Q2Q % growth | 0.00 73.33% | -0.01 | 0.01 | 61.17% |
| Q3 2022 Q2Q % growth | -0.01 40.00% | -0.01 | 0.00 | 41.75% |
| Q2 2022 Q2Q % growth | -0.01 | -0.01 | 0.00 | 41.75% |
| Q4 2021 Q2Q % growth | -0.02 -275.00% | -0.01 | 0.00 | -45.63% |
| Q3 2021 Q2Q % growth | -0.01 | -0.01 | 0.00 | 2.91% |
| Q2 2021 Q2Q % growth | -0.01 40.00% | -0.01 | 0.00 | 41.75% |
| Q1 2021 Q2Q % growth | 0.00 100.00% | -0.01 | 0.01 | 100.00% |
| Q4 2020 Q2Q % growth | 0.00 | -0.01 | 0.01 | 61.17% |
| Q3 2020 Q2Q % growth | -0.01 | -0.01 | 0.00 | 2.91% |
| Q1 2020 Q2Q % growth | -0.01 | -0.01 | 0.00 | 22.33% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 279K -19.60% | 236.9K | 42.1K | 17.77% |
| Q2 2025 Q2Q % growth | 219.74K 117.89% | 206K | 13.74K | 6.67% |
| Q1 2025 Q2Q % growth | 91.19K -47.89% | 206K | -114.81K | -55.73% |
| Q4 2024 Q2Q % growth | 410K 12.95% | 154.5K | 255.5K | 165.37% |
| Q3 2024 Q2Q % growth | 347K 23.66% | 103K | 244K | 236.89% |
| Q2 2024 Q2Q % growth | 100.85K -53.93% | 100.85K | % | |
| Q1 2024 Q2Q % growth | 175K -15.46% | 175K | % | |
| Q4 2023 Q2Q % growth | 363K 11.49% | 329.6K | 33.4K | 10.13% |
| Q3 2023 Q2Q % growth | 280.61K 7.68% | 298.7K | -18.09K | -6.06% |
| Q2 2023 Q2Q % growth | 218.9K -35.77% | 298.7K | -79.8K | -26.72% |
| Q1 2023 Q2Q % growth | 207K -2.22% | 206K | 1K | 0.49% |
| Q4 2022 Q2Q % growth | 325.6K 52.29% | 347.11K | -21.51K | -6.20% |
| Q3 2022 Q2Q % growth | 260.6K 90.50% | 206K | 54.6K | 26.50% |
| Q2 2022 Q2Q % growth | 340.8K 11.66% | 257.5K | 83.3K | 32.35% |
| Q1 2022 Q2Q % growth | 211.7K 69.63% | % | ||
| Q4 2021 Q2Q % growth | 213.8K -46.78% | 309K | -95.2K | -30.81% |
| Q3 2021 Q2Q % growth | 136.8K -41.54% | 206K | -69.2K | -33.59% |
| Q2 2021 Q2Q % growth | 305.2K 67.78% | 206K | 99.2K | 48.16% |
| Q1 2021 Q2Q % growth | 124.8K 11.93% | 103K | 21.8K | 21.17% |
| Q4 2020 Q2Q % growth | 401.7K | 103K | 298.7K | 290.00% |
| Q1 2020 Q2Q % growth | 111.5K | 51.5K | 60K | 116.50% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -25% | 0% | -100% |
| Revenue | 0% | 0% | 0% | -3.3% |